120 related articles for article (PubMed ID: 19639026)
1. Elucidating the role of 8q24 in colorectal cancer.
Harismendy O; Frazer KA
Nat Genet; 2009 Aug; 41(8):868-9. PubMed ID: 19639026
[No Abstract] [Full Text] [Related]
2. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
Pomerantz MM; Ahmadiyeh N; Jia L; Herman P; Verzi MP; Doddapaneni H; Beckwith CA; Chan JA; Hills A; Davis M; Yao K; Kehoe SM; Lenz HJ; Haiman CA; Yan C; Henderson BE; Frenkel B; Barretina J; Bass A; Tabernero J; Baselga J; Regan MM; Manak JR; Shivdasani R; Coetzee GA; Freedman ML
Nat Genet; 2009 Aug; 41(8):882-4. PubMed ID: 19561607
[TBL] [Abstract][Full Text] [Related]
3. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.
Tuupanen S; Turunen M; Lehtonen R; Hallikas O; Vanharanta S; Kivioja T; Björklund M; Wei G; Yan J; Niittymäki I; Mecklin JP; Järvinen H; Ristimäki A; Di-Bernardo M; East P; Carvajal-Carmona L; Houlston RS; Tomlinson I; Palin K; Ukkonen E; Karhu A; Taipale J; Aaltonen LA
Nat Genet; 2009 Aug; 41(8):885-90. PubMed ID: 19561604
[TBL] [Abstract][Full Text] [Related]
4. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue.
Prokunina-Olsson L; Hall JL
Mol Cancer; 2009 Nov; 8():96. PubMed ID: 19895682
[TBL] [Abstract][Full Text] [Related]
5. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
6. Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations.
Nan H; Morikawa T; Suuriniemi M; Imamura Y; Werner L; Kuchiba A; Yamauchi M; Hunter DJ; Kraft P; Giovannucci EL; Fuchs CS; Ogino S; Freedman ML; Chan AT
J Natl Cancer Inst; 2013 Dec; 105(24):1852-61. PubMed ID: 24317174
[TBL] [Abstract][Full Text] [Related]
7. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
8. Long-range enhancers on 8q24 regulate c-Myc.
Sotelo J; Esposito D; Duhagon MA; Banfield K; Mehalko J; Liao H; Stephens RM; Harris TJ; Munroe DJ; Wu X
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3001-5. PubMed ID: 20133699
[TBL] [Abstract][Full Text] [Related]
9. A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt responsive enhancers.
Yochum GS; Sherrick CM; Macpartlin M; Goodman RH
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):145-50. PubMed ID: 19966299
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
Wright JB; Brown SJ; Cole MD
Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
[TBL] [Abstract][Full Text] [Related]
11. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression.
Yochum GS; Cleland R; Goodman RH
Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287
[TBL] [Abstract][Full Text] [Related]
13. Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc.
Muncan V; Sansom OJ; Tertoolen L; Phesse TJ; Begthel H; Sancho E; Cole AM; Gregorieff A; de Alboran IM; Clevers H; Clarke AR
Mol Cell Biol; 2006 Nov; 26(22):8418-26. PubMed ID: 16954380
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants at chromosome 8q24, colorectal epithelial cell proliferation, and risk for incident, sporadic colorectal adenomas.
Yang B; Thyagarajan B; Gross MD; Goodman M; Sun YV; Bostick RM
Mol Carcinog; 2014 Feb; 53 Suppl 1():E187-92. PubMed ID: 23776012
[TBL] [Abstract][Full Text] [Related]
15. Genomic copy number of a carcinogenic single nucleotide polymorphism at 8q24 in non-risk allele colorectal cancer associated with insulin growth factor 2 receptor expression.
Takahashi Y; Mimori K; Yamamoto K; Watanabe M; Tanaka J; Kudo SE; Sugihara K; Hase K; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Mori M
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():95-9. PubMed ID: 22486879
[TBL] [Abstract][Full Text] [Related]
16. Gene variants of TCF7L2 are histopathologically important in colorectal cancers but do not have direct association with MYC expression.
Ozkan Kucuk NE; Horozoglu C; Timirci Kahraman O; Arikan S; Farooqi AA; Turan S; Korkmaz G; Kelten Talu EC; Sabitaliyevich UY; Yaylim I
Cell Mol Biol (Noisy-le-grand); 2019 Dec; 65(8):1-6. PubMed ID: 32133972
[TBL] [Abstract][Full Text] [Related]
17. Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.
Tögel L; Nightingale R; Chueh AC; Jayachandran A; Tran H; Phesse T; Wu R; Sieber OM; Arango D; Dhillon AS; Dawson MA; Diez-Dacal B; Gahman TC; Filippakopoulos P; Shiau AK; Mariadason JM
Mol Cancer Ther; 2016 Jun; 15(6):1217-26. PubMed ID: 26983878
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Wnt signaling by the nuclear pore complex.
Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
[TBL] [Abstract][Full Text] [Related]
19. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry.
Poynter JN; Figueiredo JC; Conti DV; Kennedy K; Gallinger S; Siegmund KD; Casey G; Thibodeau SN; Jenkins MA; Hopper JL; Byrnes GB; Baron JA; Goode EL; Tiirikainen M; Lindor N; Grove J; Newcomb P; Jass J; Young J; Potter JD; Haile RW; Duggan DJ; Le Marchand L;
Cancer Res; 2007 Dec; 67(23):11128-32. PubMed ID: 18056436
[TBL] [Abstract][Full Text] [Related]
20. A Rare Missense Variant in TCF7L2 Associates with Colorectal Cancer Risk by Interacting with a GWAS-Identified Regulatory Variant in the MYC Enhancer.
Chang J; Tian J; Yang Y; Zhong R; Li J; Zhai K; Ke J; Lou J; Chen W; Zhu B; Shen N; Zhang Y; Gong Y; Zhu Y; Zou D; Peng X; Huang K; Miao X
Cancer Res; 2018 Sep; 78(17):5164-5172. PubMed ID: 30026326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]